[go: up one dir, main page]

CY1113558T1 - 6-Arylalkylamino-2,3,4,5-tetrahydro-1H-benzodiazepines as 5-HT2C receptor agonists - Google Patents

6-Arylalkylamino-2,3,4,5-tetrahydro-1H-benzodiazepines as 5-HT2C receptor agonists

Info

Publication number
CY1113558T1
CY1113558T1 CY20131100065T CY131100065T CY1113558T1 CY 1113558 T1 CY1113558 T1 CY 1113558T1 CY 20131100065 T CY20131100065 T CY 20131100065T CY 131100065 T CY131100065 T CY 131100065T CY 1113558 T1 CY1113558 T1 CY 1113558T1
Authority
CY
Cyprus
Prior art keywords
tetrahydro
receptor agonists
arylalkylamino
benzodiazepines
ht2c receptor
Prior art date
Application number
CY20131100065T
Other languages
Greek (el)
Inventor
Karin Briner
Bartolome Marta Adeva
Manuel Javier Cases-Thomas
Christopher Stanley Galka
Llorente Alicia Marcos
Maria Angeles Martinez-Grau
Michael Philip Mazanetz
John Cunningham O'toole
Richard Edmund Rathmell
Matthew Robert Reinhard
Selma Sapmaz
Andrew Caerwyn Williams
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06802859A external-priority patent/EP1924561B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1113558T1 publication Critical patent/CY1113558T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει 6-υποκατεστημένες-2,3,4,5-τετραϋδρο-1Η-βενζο[d]αζεπινες του Τύπου (I) ως επιλεκτικούς αγωνιστές υποδοχέα 5-HT2c για την αγωγή των διαταραχών που συνδέονται με 5-HT2c στις οποίες περιλαμβάνονται η παχυσαρκία, η ιδεοληπτική διαταραχή, η κατάθλιψη, και το άγχος, όπου, το R6 είναι -NR10R11, όπου το R10 είναι υποκατεστημένο φαινυλαλκύλιο ή υποκατεστημένο πυριδυλαλκύλιο και οι άλλοι υποκατάστατες ορίζονται όπως στην περιγραφή.The present invention provides 6-substituted-2,3,4,5-tetrahydro-1H-benzo [d] azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c-associated disorders in which obesity, obsessive-compulsive disorder, depression, and anxiety include, wherein, R6 is -NR10R11, wherein R10 is substituted phenylalkyl or substituted pyridylalkyl and the other substituents are defined as described.

CY20131100065T 2005-09-01 2013-01-23 6-Arylalkylamino-2,3,4,5-tetrahydro-1H-benzodiazepines as 5-HT2C receptor agonists CY1113558T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05380191 2005-09-01
US73108105A 2005-10-28 2005-10-28
EP06802859A EP1924561B1 (en) 2005-09-01 2006-09-01 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists

Publications (1)

Publication Number Publication Date
CY1113558T1 true CY1113558T1 (en) 2016-06-22

Family

ID=58448880

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100065T CY1113558T1 (en) 2005-09-01 2013-01-23 6-Arylalkylamino-2,3,4,5-tetrahydro-1H-benzodiazepines as 5-HT2C receptor agonists

Country Status (1)

Country Link
CY (1) CY1113558T1 (en)

Similar Documents

Publication Publication Date Title
NO20064277L (en) 6-substituted 2,3,4,5-tetrahydro-1H-benzo [d] azepines as 5-HT 2C receptor agonists
CY1107924T1 (en) FENYL-PIPERAZINE PRODUCTS AS SEROTONIN REINFECTION INHIBITORS
TW200510324A (en) 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
CY1117619T1 (en) 8-CHLORO-1-Methyl-2,3,4,5-tetrahydro-1H-3BENZAZEPIN HYDROCHLORIDE
WO2007028083A3 (en) 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
CY1110531T1 (en) 6-Substituents-2,3,4,5-tetrahydro-1H-benzo [D] azepines as 5-HT2C receptor agonists
CY1106526T1 (en) N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES
CY1110486T1 (en) 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [D] ACEPINS AS 5-HT2C RECEPTOR RANGERS
ATE433962T1 (en) PIPERAZINYLPYRAZINE COMPOUNDS AS ANTAGONISTS OF THE SEROTONIN 5-HT2 RECEPTOR
DE69732868D1 (en) Remedy for itching
DE602006007556D1 (en) HETEROARYLSULFONYL STILENE AS 5-HT2A ANTAGONISTS
CY1114382T1 (en) 2-Cyanophenyl Synthetic Heterocyclic Compounds, and their Compositions and Uses
MXPA05007115A (en) Novel cb 1 receptor inverse agonists.
NO20062020L (en) 1-Amino-2-Oxy-Substituted Tetrahydronaphthalene Derivatives, Methods of Preparation thereof, and Their Use as Antiflogistics
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
DE502004011551D1 (en) 1,3,4-SUBSTITUTED PYRAZOLE AS 5-HT RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS
PL1626720T3 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
WO2007028132A3 (en) 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
CY1113558T1 (en) 6-Arylalkylamino-2,3,4,5-tetrahydro-1H-benzodiazepines as 5-HT2C receptor agonists
IS2425B (en) New heteroaryl derivatives, their production and use
MXPA05010627A (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors.
ATE517623T1 (en) USE OF METHYLPHENIDATE DERIVATIVES
CY1115160T1 (en) 6-Substituted 2,3,4,5-tetrahydro-1H-benzo [D] ACEPINS AS 5-HT2C RECEPTORS
ATE532514T1 (en) PIPERIDINE AND PIPERAZINE DERIVATIVES
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors